Feasibility of intratumoral anti-pd1 as treatment of human basal cell carcinoma: an explorative study with adjuvant ablative fractional laser

HIGHLIGHTS

• who: Silje Haukali Omland and collaborators from the Department of Dermatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark have published the paper: Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional Laser, in the Journal: Cancers 2022, 5815 of /2022/
• what: With the overall aim to expand the use of ICI to non-aggressive BCC, this explorative study investigates the local application of anti-PD1. The study was designed as an exploratory study; hence, no formal sample size was calculated.
• future: Future . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.